BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26323872)

  • 1. Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.
    Deekonda S; Wugalter L; Rankin D; Largent-Milnes TM; Davis P; Wang Y; Bassirirad NM; Lai J; Kulkarni V; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4683-8. PubMed ID: 26323872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.
    Deekonda S; Cole J; Sunna S; Rankin D; Largent-Milnes TM; Davis P; BassiriRad NM; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem Lett; 2016 Jan; 26(1):222-7. PubMed ID: 26611918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.
    Deekonda S; Wugalter L; Kulkarni V; Rankin D; Largent-Milnes TM; Davis P; Bassirirad NM; Lai J; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem; 2015 Sep; 23(18):6185-94. PubMed ID: 26299827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
    Rew Y; Malkmus S; Svensson C; Yaksh TL; Chung NN; Schiller PW; Cassel JA; DeHaven RN; Taulane JP; Goodman M
    J Med Chem; 2002 Aug; 45(17):3746-54. PubMed ID: 12166947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.
    Lee YS; Petrov R; Park CK; Ma SW; Davis P; Lai J; Porreca F; Vardanyan R; Hruby VJ
    J Med Chem; 2007 Nov; 50(22):5528-32. PubMed ID: 17927164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.
    Misicka A; Lipkowski AW; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
    Life Sci; 1997; 60(15):1263-9. PubMed ID: 9096243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
    Deekonda S; Rankin D; Davis P; Lai J; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4148-52. PubMed ID: 26316468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid bivalent ligands with opiate and enkephalin pharmacophores.
    Portoghese PS; Larson DL; Ronsisvalle G; Schiller PW; Nguyen TM; Lemieux C; Takemori AE
    J Med Chem; 1987 Nov; 30(11):1991-4. PubMed ID: 2444704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.
    Deekonda S; Rankin D; Davis P; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem; 2016 Jan; 24(2):85-91. PubMed ID: 26712115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.
    Lee YS; Nyberg J; Moye S; Agnes RS; Davis P; Ma SW; Lai J; Porreca F; Vardanyan R; Hruby VJ
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2161-5. PubMed ID: 17329100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding and biological activity of bivalent enkephalins.
    Costa T; Wüster M; Herz A; Shimohigashi Y; Chen HC; Rodbard D
    Biochem Pharmacol; 1985 Jan; 34(1):25-30. PubMed ID: 2981528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides.
    Gacel G; Zajac JM; Delay-Goyet P; Daugé V; Roques BP
    J Med Chem; 1988 Feb; 31(2):374-83. PubMed ID: 2828622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.
    Weltrowska G; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 2005 Jan; 65(1):36-41. PubMed ID: 15686532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
    J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
    Toth G; Russell KC; Landis G; Kramer TH; Fang L; Knapp R; Davis P; Burks TF; Yamamura HI; Hruby VJ
    J Med Chem; 1992 Jun; 35(13):2384-91. PubMed ID: 1320122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.
    Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA
    Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.